The international team of neuroscientists, led by Xiaoke Chen of Stanford University, employed cutting-edge genetic labeling techniques to illuminate a previously unidentified neural pathway. This circuit originates at the spinal cord, extends into the thalamus, traverses the cortex and brainstem, particularly the rostral ventromedial medulla (RVM), before looping back to the spinal cord. What sets this circuitry apart is its selective activation during chronic pain states, distinctly absent during normal, acute pain.

Chronic pain afflicts approximately 60 million Americans alone, presenting a complex clinical challenge due to its persistent nature even after the initial injury or inflammation has resolved. Unlike acute pain, which serves an adaptive function by signaling immediate tissue damage or threat, chronic pain is often maladaptive, characterized by a heightened sensitivity to stimuli that ordinarily would not provoke discomfort—a phenomenon known as sensitization.

The team’s innovative approach involved tagging neurons within the RVM with fluorescent proteins that glow under specific conditions, thereby exposing the circuit’s architecture and function. Remarkably, when these identified neurons in the circuit were chemically silenced in animal models, the chronic pain behaviors were alleviated while the normal acute pain responses remained fully intact. This precision suggests that the neural substrates of chronic pain can be isolated without compromising protective pain signaling.

Further experiments demonstrated that repeated activation of this identified circuit in otherwise healthy mice induced pain hypersensitivity that persisted for several weeks. This causal role establishes the neural loop as both necessary and sufficient for chronic pain sensitization. These findings signify a paradigm shift: chronic and acute pain rely on distinct and independent neural frameworks rather than a single overlapping system.

Previous scientific models emphasized the role of the periaqueductal gray (PAG) and RVM system in modulating pain, primarily suggesting this pathway as a therapeutic target for reducing pain. However, this newly described circuit appears to operate in an antagonistic fashion—where stimulation heightens pain sensitivity, opposing the analgesic effect mediated by the classical PAG-RVM pathway. This dualistic mechanism elucidates why past interventions have sometimes had limited efficacy or undesirable side effects.

The clinical implications of this discovery are profound. Because chronic pain emerges from a dedicated neuronal ensemble, pharmacological or genetic interventions could be engineered to selectively dampen this circuit’s activity. This targeted manipulation could potentially provide relief for millions of patients burdened by persistent pain without negating their ability to perceive acute pain, which is vital for survival.

Identifying molecular biomarkers and mechanistic triggers that drive the activation of these RVM neurons is an ongoing effort. Deciphering the molecular signature that shifts the circuit into a pain-promoting state might reveal novel drug targets. Such precision medicine strategies could supersede current treatments that lack specificity and frequently bear significant risks, including opioid addiction and cognitive impairment.

Intriguingly, the existence of a dedicated chronic pain circuit raises fundamental questions about the neural logic underlying persistent pain states. Since the brain itself lacks pain-sensing neurons, it presumably relies on internal signaling loops to detect and interpret sustained nociceptive information. Understanding this dedicated circuit could thus illuminate broader principles of how the nervous system encodes internal bodily states and maintains homeostasis.

This discovery also dovetails with parallel investigations exploring genetic variations in humans suffering from chronic pain conditions. By correlating molecular changes in human genetic databases with those observed in the murine models, researchers hope to validate the translational potential of these findings. This cross-species approach strengthens the likelihood of developing effective treatments that are safe and broadly applicable.

Technologically, this study harnessed advanced optogenetics and chemogenetics, enabling selective control and observation of neural populations in vivo. Such tools have revolutionized neuroscience by allowing precise mapping of functional circuits and directly testing their causal roles in behavior and sensation, rather than merely identifying correlative markers.

The decomposition of this spino-brain–spinal cord loop represents a major leap forward in neuroscience, restoring hope for chronic pain sufferers. As therapies targeting this circuit are developed, future clinical approaches may finally offer the elusive combination of efficacy and safety once considered unattainable in pain management.

In summary, the revelation of a distinct brain circuit dedicated to chronic pain sensitization fundamentally reshapes our understanding of pain neurobiology. It also presents a promising horizon for therapeutic innovation, potentially enabling millions to regain quality of life while preserving the indispensable warnings mediated by acute pain.

Subject of Research: Animals

Article Title: Deconstruction of a spino-brain–spinal cord circuit that drives chronic pain

News Publication Date: 1-Apr-2026

Web References:
http://dx.doi.org/10.1038/s41586-026-10296-y

Image Credits: Courtesy Xiaoke Chen/Stanford University

Keywords: Chronic pain, Neuroscience, Cellular neuroscience, Behavioral neuroscience, Clinical neuroscience, Molecular biology, Cell biology

The medial prefrontal cortex, a critical region nestled in the frontal lobes of the brain, has long been recognized for its role in personality, decision-making, and emotional regulation. Despite decades of research, the exact circuitry by which this brain region integrates myriad sensory inputs with internal physiological states to produce adaptive or maladaptive behavioral responses remained elusive. The UCLA team employed cutting-edge techniques—combining genetic labeling strategies, high-resolution 3D brain imaging, and artificial intelligence-driven circuit mapping—to dissect the fine-scale connectivity and organization of mouse mPFC subregions, specifically the dorsal peduncular area (DP) and infralimbic area (ILA).

Employing genetically encoded tracers, the researchers traced neuronal projections and synaptic partners within the mPFC, constructing a detailed wiring diagram of these visceromotor hubs. These areas act as integrative nodes, synthesizing information related to external sensory stimuli and internal bodily signals, such as those from the autonomic nervous system, to coordinate behavioral and physiological responses to stress. The sophisticated AI tools developed for this study enabled the automated reconstruction of neuronal circuits in three dimensions, revealing previously unseen patterns of connectivity and interregional communication.

One of the most compelling insights from this work concerns how these mPFC hubs not only modulate emotional reactivity but maintain emotional stability through balanced excitatory and inhibitory circuits. Dysregulations in this delicate balance could underlie the emotional instability observed in myriad psychiatric disorders. By elucidating the precise synaptic arrangements and molecular identities of these neurons, the study provides a cellular-level blueprint that parallels similar visceromotor circuits conserved in the human ventromedial prefrontal cortex (vmPFC).

The implications of these findings echo a historical neuroscience narrative dating back over 170 years to the famous case of Phineas Gage, a railroad worker who survived a traumatic frontal lobe injury yet underwent profound personality changes. Gage’s case underscored the significance of the prefrontal cortex in governing social behavior and emotional regulation. However, the neural underpinnings of such personality alterations have long remained a mystery. This research takes a pivotal step toward filling that knowledge gap and directly links mPFC circuitry to the regulation of complex behaviors and stress responses.

Moreover, the study’s integration of advanced 3D reconstructions with AI-driven analysis sets a new standard for investigating brain architecture at the mesoscale level. This methodological breakthrough not only accelerates data acquisition and analysis but also enhances reproducibility, offering an unprecedented resolution for mapping brain circuits involved in neuropsychiatric disorder pathophysiology.

Beyond the fundamental scientific advancements, this work holds profound clinical relevance. By pinpointing the neuronal circuits that orchestrate physiological and emotional responses to stress, the UCLA team offers promising targets for the development of novel, precision-based therapeutic interventions. These may one day include targeted neuromodulation, pharmacological agents aimed at circuit-specific molecular markers, and improved diagnostic tools capable of identifying early signs of neuropsychiatric dysfunction.

Additionally, the study raises intriguing questions about the interaction between brain regions responsible for integrating internal bodily states and those processing external environmental information. Understanding how these networks synchronize to generate coherent behavior under stress has enormous implications for tackling disorders characterized by impaired emotional regulation and social cognition.

The researchers underscore that the cellular and circuit-level insights gained from mice are highly relevant to human brain function due to evolutionary conservation of mPFC structures and connectivity patterns. This conservation bolsters the translational potential of the findings, suggesting that future therapies targeting homologous human brain circuits could mitigate the debilitating effects of mood and anxiety disorders.

Furthermore, this research exemplifies how multidisciplinary approaches—bridging genetics, neuroanatomy, computational modeling, and behavioral neuroscience—can unravel the complexities of brain function. Such holistic perspectives are vital for deciphering the labyrinth of neural interactions that underlie human cognition, emotion, and behavior.

In summary, the UCLA-led study provides a seminal contribution to neuroscience by delivering a comprehensive, high-resolution map of the mouse medial prefrontal cortex’s visceromotor circuits. This work not only enriches our fundamental understanding of emotional and stress regulation but also charts a course toward innovative interventions addressing some of the most pressing challenges in mental health today. As Dr. Hong Wei Dong, the study’s lead author and director of the UCLA Brain Research & Artificial Intelligence Nexus, eloquently stated, this is “a wiring diagram of one of the brain’s most mysterious control centers,” opening the floodgates to targeted therapies for stress-related and social dysfunction disorders.

Subject of Research: Animals
Article Title: Neural networks of the mouse visceromotor cortex
News Publication Date: 27-Aug-2025
Web References: https://www.nature.com/articles/s41586-025-09360-w, http://dx.doi.org/10.1038/s41586-025-09360-w
References: Dong, H.W., et al. (2025). Neural networks of the mouse visceromotor cortex. Nature. DOI: 10.1038/s41586-025-09360-w
Keywords: Behavioral neuroscience, Psychiatry, Mental health, Psychiatric disorders, Neuroscience, Anxiety disorders, Behavior disorders